Medical News Today (MNT) wrote, "By devising a way to produce retinal ganglion cells from stem cells derived from individual patients, researchers hope to improve personalized treatments for glaucoma." Read more.
Related MNT story: "Using stem cells
derived from human skin cells, researchers led by Jason Meyer,
assistant professor of biology, along with graduate student Sarah
Ohlemacher of the School of Science at Indiana University-Purdue
University Indianapolis, have successfully demonstrated the ability to
turn stem cells into retinal ganglion cells (RGCs), the neurons that
conduct visual information from the eye to the brain. Their goal is the
development of therapies to prevent or cure glaucoma." Read more.